Literature DB >> 20041095

Time for global efforts with clinical trials for advanced cervical cancer patients.

Mison Chun1.   

Abstract

Entities:  

Year:  2009        PMID： 20041095      PMCID： PMC2799015          DOI： 10.3802/jgo.2009.20.4.201

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN： 2005-0380            Impact factor:   4.401


× No keyword cloud information.
  15 in total

1.  Treatment outcomes and prognostic factors in uterine cervical cancer patients treated with postoperative extended field radiation therapy.

Authors:  Hak Jae Kim; Sung Whan Ha; Hong-Gyun Wu
Journal:  J Gynecol Oncol       Date:  2009-12-28       Impact factor: 4.401

2.  Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study.

Authors:  M A Varia; B N Bundy; G Deppe; R Mannel; H E Averette; P G Rose; P Connelly
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-12-01       Impact factor: 7.038

3.  A prospective phase I-II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment.

Authors:  Fernanda G Herrera; Philip Chan; Corinne Doll; Michael Milosevic; Amit Oza; Amy Syed; Melania Pintilie; Wilfred Levin; Lee Manchul; Anthony Fyles
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-10-23       Impact factor: 7.038

Review 4.  Cyclooxygenase-2 in cervical neoplasia: a review.

Authors:  Jennifer L Young; Amir A Jazaeri; Christopher J Darus; Susan C Modesitt
Journal:  Gynecol Oncol       Date:  2008-02-13       Impact factor: 5.482

5.  Cyclooxygenase-2 expression as a predictor of para-aortic lymph node recurrence in uterine cervical cancer.

Authors:  Jun-Sang Kim; Shengjin Li; Jin-Man Kim; Seung-Gu Yeo; Ki-Hwan Kim; Moon-June Cho
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-04       Impact factor: 7.038

6.  Epidemiology, prevention and treatment of cervical cancer in the Philippines.

Authors:  Efren J Domingo; Ana Victoria V Dy Echo
Journal:  J Gynecol Oncol       Date:  2009-03-31       Impact factor: 4.401

7.  Gynecological cancer in Indonesia.

Authors:  M Farid Aziz
Journal:  J Gynecol Oncol       Date:  2009-03-31       Impact factor: 4.401

8.  A phase I/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes: a Gynecologic Oncology Group study.

Authors:  Joan L Walker; Astrid Morrison; Paul DiSilvestro; Vivian E von Gruenigen
Journal:  Gynecol Oncol       Date:  2008-11-17       Impact factor: 5.482

9.  Correlation between tumor volume response to radiotherapy and expression of biological markers in patients with cervical squamous cell carcinoma.

Authors:  Jae Myoung Noh; Won Park; Seung Jae Huh; Eun Yoon Cho; Yoon-La Choi; Je Ho Lee; Duk Soo Bae
Journal:  J Gynecol Oncol       Date:  2009-12-28       Impact factor: 4.401

Review 10.  Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology Group.

Authors:  Krishnansu S Tewari; Bradley J Monk
Journal:  Semin Oncol       Date:  2009-04       Impact factor: 4.929
View more
  1 in total

1.  Clinical outcome of FIGO 2018 stage IB3/IIA2 cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery due to lack of radiotherapy equipment: A retrospective comparison with concurrent chemoradiotherapy.

Authors:  Jing Zeng; Peisong Sun; Quanhong Ping; Shan Jiang; Yuanjing Hu
Journal:  PLoS One       Date:  2022-03-24       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.